Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1187
TNBC
Basal A
Omipalisib
PI3K
PI3K
10753.087
uM
0.00781
0.11198
-0.7496 -0.8691 0.3783 0.8322
0.9577
1.4150
HCC1187
TNBC
Basal A
Omipalisib
PI3K
PI3K
10518.087
uM
0.00488
0.02658
-0.7747 -0.7029 0.5176 0.9208
0.9758
1.1688
HCC1187
TNBC
Basal A
Omipalisib
PI3K
PI3K
7431.087
uM
0.00598
0.03287
-0.9178 -0.9240 0.6143 1.0229
0.9965
1.4117
HCC1187
TNBC
Basal A
Oxaliplatin
DNA cross-linker
DNA cross-linker
7811.011
uM
0.26894
0.77535
-1.0000 -1.0000 1.0376 1.1173
0.9558
0.4400
HCC1187
TNBC
Basal A
Oxaliplatin
DNA cross-linker
DNA cross-linker
7812.011
uM
1.3180
3.08130
-0.9863 -0.9483 1.2523 0.7877
0.9956
1.0620
HCC1187
TNBC
Basal A
Oxaliplatin
DNA cross-linker
DNA cross-linker
9244.021
uM
2.44470
3.04470
-0.9997 -0.9980 5.0000 0.8270
0.9985
0.4542
HCC1187
TNBC
Basal A
Oxamflatin
HDAC
HDAC
10753.147
uM
0.64075
1.52210
-0.9518 -0.9833 1.2568 0.5945
0.9948
1.2493
HCC1187
TNBC
Basal A
PD 98059
MEK
MAPK
10753.152
uM
3.02630
80.71050
0.0736 -1.0000 0.3346 0.2977
0.9487
1.3690
HCC1187
TNBC
Basal A
PD 98059
MEK
MAPK
10518.136
uM
5.70580
6.65780
-0.0226 -0.0746 0.9009 0.2276
0.9698
1.2490
HCC1187
TNBC
Basal A
PD173074
FGFR1/3
RTK
10518.1
uM
11.85830
18.21780
-0.9484 -1.0000 2.5586 0.2835
0.9690
1.4056
HCC1187
TNBC
Basal A
PD173074
FGFR1/3
RTK
7431.1
uM
11.70780
18.80630
-0.9046 -1.0000 2.3180 0.2116
0.9980
1.5594
HCC1187
TNBC
Basal A
PD184352
MEK
MAPK
7812.029
uM
inf
inf
1.0500 1.0500 0.0000 0.0727
0.0526
0.9642
HCC1187
TNBC
Basal A
PD184352
MEK
MAPK
7812.029
uM
inf
inf
1.0500 1.0500 0.0000 0.0727
0.0526
0.9642
HCC1187
TNBC
Basal A
PD184352
MEK
MAPK
10753.146
uM
inf
inf
0.7681 0.7681 0.0000 0.1159
0.2362
1.4503
HCC1187
TNBC
Basal A
PD184352
MEK
MAPK
10753.146
uM
inf
inf
0.7681 0.7681 0.0000 0.1159
0.2362
1.4503
HCC1187
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7433.095
uM
inf
inf
0.2099 0.2099 0.0000 0.6689
0.1148
0.9260
HCC1187
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7432.095
uM
inf
inf
1.0222 1.0222 0.0000 0.0161
0.1254
0.8368
HCC1187
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7431.095
uM
inf
inf
0.5824 0.5824 0.0000 0.2553
0.5276
1.2776
HCC1187
TNBC
Basal A
PS-1145
IKK
NFKB
7433.065
uM
inf
1000.00000
0.6429 0.4284 0.5172 0.0654
0.7671
0.8820
HCC1187
TNBC
Basal A
PS-1145
IKK
NFKB
7432.065
uM
3427.84650
1000.00000
0.5758 0.3739 1.1179 0.0234
0.9259
0.7981
HCC1187
TNBC
Basal A
PS-1145
IKK
NFKB
7431.065
uM
inf
144.79520
0.5837 0.5461 1.1241 0.0908
0.9332
1.4650
HCC1187
TNBC
Basal A
Purvalanol A
CDK1
CDK
7433.067
uM
9.47940
10.1330
-0.8740 -0.1978 5.0000 0.2638
0.7081
1.0142
HCC1187
TNBC
Basal A
Purvalanol A
CDK1
CDK
7432.067
uM
22.79160
21.31010
0.0795 0.0553 1.7444 0.1425
0.9753
1.0373
HCC1187
TNBC
Basal A
Ribavirin
15300.211
uM
48.18310
61.54250
0.4912 -0.1113 0.8215 0.1121
0.6468
0.8961
HCC1187
TNBC
Basal A
Ro 32-0432
PKC
PKC
10518.142
uM
inf
inf
0.9965 0.9965 0.0000 0.0075
0.0002
1.2869